Speaker illustration

Doctor Monica Mariana Baluta

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

Patients with prosthetic valve endocarditis admitted in non-reference centers may substantially benefit from infectious diseases specialist wisdom in antibiotic regimen selection

Event: Heart Failure 2019

Topic: Treatment

Session: Valvular Heart Disease

Thumbnail

Type 2 diabetes is a strong predictor of mortality in patients with prosthetic valve endocarditis with or without heart failure

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease

Thumbnail

Anemia is an independent risk factor of adverse outcome in patients with prosthetic valve endocarditis and heart failure

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular Heart Disease – Epidemiology, Prognosis, Outcome

Thumbnail

Anticoagulant strategy for prosthetic valve in patients with endocarditis does not influence anemia, preexistent heart failure and mortality

Event: Heart Failure 2018

Topic: Treatment

Session: Valvular Heart Disease – Treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb